Discover how a remote therapeutic monitoring system enhances patient care and streamlines clinic operations, reducing hospitalizations for hematologic malignancies.
James Essell, MD
Advertisement
James Essell, MD, is a medical oncologist at Sarah Cannon Research Institute at OHC, the US Oncology Network.
Articles by James Essell, MD
Remote therapeutic monitoring significantly lowers infection-related hospitalizations in hematological cancer patients, enhancing outpatient care and reducing emergency visits.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
CARTITUDE-4: Cilta-Cel May Offer Curative Potential in Standard-Risk R/R Myeloma
2
Teclistamab Plus Daratumumab Significantly Improves Survival in R/R Myeloma
3
NCCN Guidelines in nccRCC Weigh New Data for Combinations
4
Pirtobrutinib Superior to BR in First-Line CLL/SLL: BRUIN CLL-313 Results
5
